Bombay High Court Rejects Adani Plea That Duty-Free Shops Are Beyond Domestic Laws
The Bombay High Court has rejected a plea by an Adani Group-linked airport retailer that goods sold through duty-free shops at an international airport are beyond the reach of Indian domestic regulations. The ruling came in a dispute over the sale of nicotine pouches at Mumbai’s Chhatrapati Shivaji Maharaj International Airport.
A Division Bench of Justice Suman Shyam and Justice Advait M. Sethna held that duty-free shops operating in international departure areas do not receive blanket immunity from Indian regulatory and public-health laws. The court distinguished between exemptions from taxes and customs duties and compliance with other domestic laws.
The court’s order stated that goods brought into a duty-free shop within Indian territorial jurisdiction remain subject to the regulatory regime applicable in India, even when the shop is located beyond the customs barrier. The decision therefore rejects the broader proposition that the customs status of an airport retail area places it outside Indian law.
The dispute concerns nicotine pouches that were being sold at duty-free outlets operated by Mumbai Travel Retail, an Adani Group-linked company. Indian authorities had objected to the products, maintaining that their sale without the necessary regulatory approval or licence violated applicable drug laws.
The company challenged the authorities’ action and argued that international departure-area duty-free shops are effectively outside India’s territorial jurisdiction for the relevant purposes. It also maintained that nicotine pouches were not “drugs” under the applicable Indian regulatory framework and described them as a relatively new product category.
The government took a different position, arguing that duty-free treatment primarily concerns taxation and customs duties and does not create a general exemption from non-fiscal laws. Authorities described the stocking of nicotine pouches as a violation of drug regulations and raised public-health concerns.
The High Court did not finally determine whether nicotine pouches themselves fall within the statutory definition of “drugs.” Instead, it said the Adani-linked retailer could place supporting material before the relevant drug regulator and seek a determination on that question.
The immediate effect of the ruling is that the challenge to the authorities’ action against the sale of the nicotine pouches has not succeeded. The court declined to interfere with the Drugs Control Department’s decision concerning the products’ sale at the Mumbai airport duty-free outlets.
The judgment also reinforces an important legal distinction surrounding the term “duty-free.” Such shops can receive fiscal benefits relating to customs duties and certain taxes, but that status does not automatically remove goods from other Indian regulatory frameworks. A duty-free transaction therefore cannot, by itself, be treated as a licence to bypass non-tax regulatory requirements.
The issue has significance beyond nicotine products because the Adani Group operates multiple airports in India and has been expanding its airport-related commercial businesses. Reuters reported that the group manages eight Indian airports and has an approximately $11 billion expansion plan, including ambitions involving duty-free retail.
The Bombay High Court’s decision consequently places the focus on the limits of the duty-free model: fiscal concessions at international airport shops do not, by themselves, create a separate legal zone beyond India’s domestic regulatory framework. The question of whether particular products can legally be sold will continue to depend on the specific laws and approvals governing those products.
